Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study.

Doctors tested leftover amniotic fluid from pregnancies. They looked for MMP-9, a protein that cuts other proteins.

The sample came from mothers whose children later got an autism diagnosis. Controls were kids without autism.

Autism pregnancies had higher MMP-9 levels. The rise hints at early brain changes before birth.

The study is small, so the finding needs repeat checks.

Bouck et al. (2016) extends this idea. They studied a large California group and linked low uE3, high MSAFP, and odd hCG patterns to later autism. Both papers hunt for prenatal warning signs, just in different fluids.

Peters et al. (2013) conceptually replicate the prenatal theme. They show mothers of autistic kids carry antibodies that stick to 37/73 kDa fetal brain proteins. Again, the mother's body signals risk before birth.

Piwowarczyk et al. (2020) seem to clash. They found newborn bloodspot fats do not predict autism. The difference is timing: amniotic fluid is months older than a newborn heel-prick. Early markers can fade by birth.

You cannot run amniocentesis on every pregnancy, but the work tells us autism biology starts early. Keep watching for new prenatal screens that are safe and cheap. For now, use the data to reassure families that autism roots are biological, not parenting style.